We have located links that may give you full text access.
Efficacy of platelet-rich plasma injections for symptomatic tendinopathy: systematic review and meta-analysis of randomised injection-controlled trials.
AIM: To determine the efficacy of platelet-rich plasma (PRP) injections for symptomatic tendinopathy.
DESIGN: Systematic review of randomised, injection-controlled trials with meta-analysis.
DATA SOURCES: Systematic searches of MEDLINE and EMBASE, supplemented by manual searches.
ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Randomised controlled trials with 3 months minimum follow-up that evaluated pain reduction with PRP versus control (saline, local anaesthetic, corticosteroid) injections in patients with symptomatic tendinopathy.
RESULTS: A total of 16 randomised controlled trials (18 groups) of PRP versus control were included. Median sample size was 35 patients, a study size that would require an effect size ≥1.0 to achieve statistical significance. PRP was more efficacious than control in reducing tendinopathy pain, with an effect size of 0.47 (95% CI 0.22 to 0.72, p<0.001), signifying a moderate treatment effect. Heterogeneity among studies was moderate (I2 =67%, p<0.001). In subgroup analysis and meta-regression, studies with a higher proportion of female patients were associated with greater treatment benefits with PRP.
CONCLUSIONS: Injection of PRP is more efficacious than control injections in patients with symptomatic tendinopathy.
DESIGN: Systematic review of randomised, injection-controlled trials with meta-analysis.
DATA SOURCES: Systematic searches of MEDLINE and EMBASE, supplemented by manual searches.
ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Randomised controlled trials with 3 months minimum follow-up that evaluated pain reduction with PRP versus control (saline, local anaesthetic, corticosteroid) injections in patients with symptomatic tendinopathy.
RESULTS: A total of 16 randomised controlled trials (18 groups) of PRP versus control were included. Median sample size was 35 patients, a study size that would require an effect size ≥1.0 to achieve statistical significance. PRP was more efficacious than control in reducing tendinopathy pain, with an effect size of 0.47 (95% CI 0.22 to 0.72, p<0.001), signifying a moderate treatment effect. Heterogeneity among studies was moderate (I2 =67%, p<0.001). In subgroup analysis and meta-regression, studies with a higher proportion of female patients were associated with greater treatment benefits with PRP.
CONCLUSIONS: Injection of PRP is more efficacious than control injections in patients with symptomatic tendinopathy.
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app